This message was sent to ##Email##
|
| June 13, 2018 |
| |  | | |
|
|
|
| |
ASCT
Breast FNAB cytology has a long history of providing accurate, rapid and cost-effective diagnoses of palpable and impalpable breast lesions. It is one of the most common fine needle aspiration biopsy (FNAB) procedures performed in the world, especially in developing countries, but has faced challenges in recent times related to the use of core needle biopsies. There have been many advances in the diagnostic workup of breast lesions, since the NCI meeting in 1996, in breast cytology, imaging and the management of breast lesions. In this setting, the International Academy of Cytology (IAC) brought a group of expert cytopathologists, radiologists and clinicians together to develop a Breast FNAB Reporting System and they met for the first time in Yokohama at the International Cytology Conference in 2016.
This Group has developed a reporting system and a questionnaire has been created to seek the opinions of the international cytopathology community on the draft stage of the system. We thank Dan Kurtycz for his assistance and the University of Wisconsin for hosting the questionnaire on their website.
We would encourage all cytopathologists and cytotechnologists to provide feedback to the group by completing this survey. It may appear long, but many of the questions are simple "yes/no." There are ample opportunities for more detailed input.
We look forward to reviewing the findings of the survey and the specific comments. These will inform the group and the final Yokohama IAC Breast FNAB Reporting System. The survey will close on Saturday, June 30.
| Congratulations to our 2018 cytotechnology graduates!
|
    |
ASCT
ASCT wishes you the best in your new profession. Remember to avail yourselves of the ASCT Career Center, a free service that provides access to cytotechnology positions and employers. In addition to posting their resumes, job seekers can browse and view available jobs based on their criteria and save those jobs for later review if they choose. Job seekers can also create a search agent to provide email notifications of jobs that match their criteria. You can access the Career Center from the tab at the top bar of all Viewpoints.
Employers can post jobs online, search for qualified candidates based on specific job criteria, and create an online resume agent to email qualified candidates daily. They also benefit from online reporting that provides job activity statistics.
As a registered employer or job seeker you also have access to the National Healthcare Career Network (NHCN), a network of over 60 top healthcare associations and professional organizations. ASCT's alliance with NHCN increases your reach to over 7,000 resumes and over 1,500 job postings — giving you more control over your career advancement and a one-stop-shop to find targeted and quality candidates.
ASCT also offers resume and interviewing tips in the Student Forum section of the ASCT website. Good luck!
| Date |
Event |
Location |
More information |
June 20, 2018 |
The Bethesda System for Cervical Cytology — Update and Beyond
|
Your PC |
Patricia G. Tiscornia-Wasserman, MD
Professor of Pathology and Cell Biology
Director of Cytopathology
Columbia University Medical Center
Melville, New York
Details
|
July 2018 |
Milan System for Salivary Gland FNA
|
Your PC |
Esther Diana Rossi, MD, PhD, MIAC
Division of Anatomic Pathology and Histology
Catholic University “Agostino Gemelli” School of Medicine
Rome, Italy
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
May 3 - 5, 2019 |
2019 ASCT Annual Conference
|
San Juan, Puerto Rico |
Details |
HealthDay News
Immunizing girls against human papillomavirus (HPV) doesn't increase their risk for autoimmune diseases, according to new research from Canada.
HPV is the world's most common sexually transmitted disease, affecting up to 75 percent of sexually active people and is the main cause of cervical cancer. Gardisil, the quadrivalent HPV4 vaccine, protects against up to 90 percent of strains that cause cervical and rectal cancer.
READ MORE
CAP TODAY
The Milan System for Reporting Salivary Gland Cytopathology was published Jan. 31 and is an important step toward standardizing the reporting of salivary gland fine needle aspiration. A large body of literature has demonstrated that FNA is an effective method for the initial evaluation of salivary gland masses, but until this year there was no uniform, widely accepted reporting system.
READ MORE
HealthDay News via Oncology Nurse Advisor
Human papillomavirus (HPV) vaccines protect against cervical precancer in adolescent girls and young women, according to a review published online May 9 in the Cochrane Library.
Marc Arbyn, M.D., from the Belgian Cancer Centre in Brussels, and colleagues conducted a systematic literature review to examine the harms and protection of prophylactic HPV vaccines against cervical precancer and HPV16/18 infection using data from 26 trials with 73,428 participants.
READ MORE
Healio
Women appeared less likely than men to receive intensive treatment for head and neck cancer, according to study results presented at ASCO Annual Meeting.
When researchers controlled for factors such as age and serious medical conditions, their analysis showed the ratio of cancer mortality to noncancer mortality was twice as high among women than men.
The findings suggest women with head and neck cancer may be undertreated. However, due to confounding factors, additional prospective study is needed to confirm this possibility.
READ MORE
Healthline
A survey of veterans showed an increase in “watchful waiting” in prostate cancer treatment. This “wait and see” attitude is spreading.
READ MORE
Medical News Today
An experimental form of immunotherapy completely obliterated breast cancer in a patient who had previously been failed by all other treatments.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
